FDA Application
-
NDC Search Results on Active Ingredient: bosentan
Click on Active Ingredient to view the label.
| Ingredient Name | NDC | Company Name | Application Number or Regulatory Citation | Product Type | Marketing Category |
|---|---|---|---|---|---|
| BOSENTAN | 68382-446-30 | Zydus Pharmaceuticals USA Inc. | ANDA207760 | HUMAN PRESCRIPTION DRUG | ANDA |
| BOSENTAN | 70771-1017-2 | Zydus Lifesciences Limited | ANDA207760 | HUMAN PRESCRIPTION DRUG | ANDA |
| BOSENTAN | 66215-101-03 | Actelion Pharmaceuticals US, Inc. | NDA021290 | HUMAN PRESCRIPTION DRUG | NDA |
| BOSENTAN | 68382-447-14 | Zydus Pharmaceuticals USA Inc. | ANDA207760 | HUMAN PRESCRIPTION DRUG | ANDA |
| BOSENTAN | 70771-1018-2 | Zydus Lifesciences Limited | ANDA207760 | HUMAN PRESCRIPTION DRUG | ANDA |
| BOSENTAN | 66215-103-56 | Actelion Pharmaceuticals US, Inc. | NDA209279 | HUMAN PRESCRIPTION DRUG | NDA |
| BOSENTAN | 68382-446-14 | Zydus Pharmaceuticals USA Inc. | ANDA207760 | HUMAN PRESCRIPTION DRUG | ANDA |
| BOSENTAN | 70771-1018-6 | Zydus Lifesciences Limited | ANDA207760 | HUMAN PRESCRIPTION DRUG | ANDA |
| BOSENTAN | 47335-039-86 | Sun Pharmaceutical Industries, Inc. | ANDA209324 | HUMAN PRESCRIPTION DRUG | ANDA |
| BOSENTAN | 70771-1018-8 | Zydus Lifesciences Limited | ANDA207760 | HUMAN PRESCRIPTION DRUG | ANDA |
| BOSENTAN | 0591-2511-60 | Actavis Pharma, Inc. | ANDA207110 | HUMAN PRESCRIPTION DRUG | ANDA |
| BOSENTAN | 47335-038-86 | Sun Pharmaceutical Industries, Inc. | ANDA209324 | HUMAN PRESCRIPTION DRUG | ANDA |
| BOSENTAN | 66215-102-06 | Actelion Pharmaceuticals US, Inc. | NDA021290 | HUMAN PRESCRIPTION DRUG | NDA |
| BOSENTAN | 66215-101-06 | Actelion Pharmaceuticals US, Inc. | NDA021290 | HUMAN PRESCRIPTION DRUG | NDA |
| BOSENTAN | 66215-102-03 | Actelion Pharmaceuticals US, Inc. | NDA021290 | HUMAN PRESCRIPTION DRUG | NDA |
| BOSENTAN | 70771-1018-1 | Zydus Lifesciences Limited | ANDA207760 | HUMAN PRESCRIPTION DRUG | ANDA |
| BOSENTAN | 47335-038-60 | Sun Pharmaceutical Industries, Inc. | ANDA209324 | HUMAN PRESCRIPTION DRUG | ANDA |
| BOSENTAN | 70771-1017-6 | Zydus Lifesciences Limited | ANDA207760 | HUMAN PRESCRIPTION DRUG | ANDA |
| BOSENTAN | 68382-447-30 | Zydus Pharmaceuticals USA Inc. | ANDA207760 | HUMAN PRESCRIPTION DRUG | ANDA |
| BOSENTAN | 68382-446-05 | Zydus Pharmaceuticals USA Inc. | ANDA207760 | HUMAN PRESCRIPTION DRUG | ANDA |
| BOSENTAN | 70771-1017-8 | Zydus Lifesciences Limited | ANDA207760 | HUMAN PRESCRIPTION DRUG | ANDA |
| BOSENTAN | 70771-1017-5 | Zydus Lifesciences Limited | ANDA207760 | HUMAN PRESCRIPTION DRUG | ANDA |
| BOSENTAN | 68382-446-77 | Zydus Pharmaceuticals USA Inc. | ANDA207760 | HUMAN PRESCRIPTION DRUG | ANDA |
| BOSENTAN | 70771-1018-5 | Zydus Lifesciences Limited | ANDA207760 | HUMAN PRESCRIPTION DRUG | ANDA |
| BOSENTAN | 47335-039-60 | Sun Pharmaceutical Industries, Inc. | ANDA209324 | HUMAN PRESCRIPTION DRUG | ANDA |
| BOSENTAN | 68382-447-77 | Zydus Pharmaceuticals USA Inc. | ANDA207760 | HUMAN PRESCRIPTION DRUG | ANDA |
| BOSENTAN | 70771-1017-4 | Zydus Lifesciences Limited | ANDA207760 | HUMAN PRESCRIPTION DRUG | ANDA |
| BOSENTAN | 66215-232-14 | Actelion Pharmaceuticals US, Inc. | NDA209279 | HUMAN PRESCRIPTION DRUG | NDA |
| BOSENTAN | 70771-1017-1 | Zydus Lifesciences Limited | ANDA207760 | HUMAN PRESCRIPTION DRUG | ANDA |
| BOSENTAN | 66215-103-14 | Actelion Pharmaceuticals US, Inc. | NDA209279 | HUMAN PRESCRIPTION DRUG | NDA |
| 1-30 | 31-42 |
-
